NCT01965925View on ClinicalTrials.gov

Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

November 9, 2017

Study Completion Date

November 9, 2017

Conditions
Bipolar Disorder
Interventions
DRUG

Modafinil

Ratio of 2:1 subjects will be in the experimental arm receiving modafinil for 8 weeks.

DRUG

Placebo

For every randomly assigned 2 subjects receiving active drug, 1 will be randomly assigned to receive placebo for 8 weeks.

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT01965925 - Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil | Biotech Hunter | Biotech Hunter